Navigation Links
Allied Healthcare Products Reports Loss On Depressed Sales
Date:5/10/2013

ST. LOUIS, May 10, 2013 /PRNewswire/ -- The continuing recession in domestic hospital equipment and a dip in international sales resulted in a loss for Allied Healthcare Products (NASDAQ: AHPI) in its third quarter of fiscal year 2013.

Net loss for the quarter ending March 31, 2013, was about $280,000, or a negative 3 cents per basic and diluted share, versus a loss of about $146,000, or a negative 2 cents per basic and diluted share, for the prior year. Sales for the third quarter fell from about $10.7 million to about $9.2 million, or almost 14 percent, from the previous year.

For the first three quarters of fiscal 2013, Allied's net loss was $1,158,800 or a negative 14 cents per basic and diluted share, compared to a loss of about $268,000, or negative 3 cents per basic and diluted share, for the prior year. Sales for the company's first three quarters declined from about $32.8 million to $28.4 million, or about 13 percent, from the previous year.

Formerly healthy international sales flattened in the quarter. A major impact was the lack of sales in Venezuela following the illness and death of President Hugo Chavez .

The company is beginning to see good growth in sales with its new carbon dioxide absorbent Litholyme®, used in anesthesia procedures, according to Earl Refsland , Allied president and chief executive officer. "As the market becomes aware of the product's economic and safety benefits, we believe sales will accelerate accordingly," Refsland said.

In a one-time event, Allied booked about $516,000 in income in January 2013 from the demutualization and sale of its product liability insurer.

In what will be a recurring expense, Allied paid a new excise tax on medical devices levied as part of the Affordable Care Act
'/>"/>

SOURCE Allied Healthcare Products, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Allied Healthcare Products Reports Second Quarter Loss
2. Allied Healthcare Reports First Quarter Loss
3. Allied Healthcare Products Reports Loss on Sales Decline
4. BidMed Awarded Equipment Liquidation and Related Services Agreement with the Premier Healthcare Alliance
5. Millennium HealthCare Signs Exclusive Distribution Agreement with Heart Smart Inc.
6. Cynosure to Present at UBS Global Healthcare Conference
7. Smart Water Leadership Summit Focused On Waterborne Disease Prevention in Healthcare Facilities To Be Held In Chicago June 6 & 7
8. Millennium HealthCare Signs Distribution Agreement with Atossa Genetics
9. Change Healthcares Clayton Nicholas to Speak on "Game Mechanics and Other Game Changers in Benefits Education" at IHC Forum East
10. Medifirst Solutions, Inc. Announces New Healthcare And Wellness Division
11. XBiotech to Present at UBS Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 29, 2015  Cepheid (Nasdaq: CPHD ... update to Xpert® Carba-R, with the addition of ... The on-demand, molecular test also detects and differentiates ... resistance, namely KPC, NDM, VIM, IMP-1 and OXA-48. ... CROs or Superbugs, are a growing and expensive ...
(Date:7/29/2015)... HERTFORDSHIRE, England and PITTSBURGH ... MYL ) today announced that it received regulatory clearance ... Regulation (EUMR) for its proposed acquisition of Perrigo Company ... Mylan,s Executive Chairman Robert J. Coury commented, ... of completing our acquisition of Perrigo and serves as ...
(Date:7/29/2015)... VIEW, Calif. , July 29, 2015  Efforts ... the growth strategy of pharmaceutical firms in ... . The realization is that an effective working capital ... pricing pressures and patent cliffs. Big pharma companies expect ... returns. Logo - http://photos.prnewswire.com/prnh/20150724/241957LOGO ...
Breaking Medicine Technology:'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 2'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 3'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 4Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 2Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 3Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 4Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 5Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 6Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 7Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 8Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 9Working Capital Management Seizes Priority in North American and European Pharma Industry 2Working Capital Management Seizes Priority in North American and European Pharma Industry 3Working Capital Management Seizes Priority in North American and European Pharma Industry 4
... and Pipeline Analysis, 4th Edition Now Available... -- DALLAS, September 28, 2010 ... ... --> ... = ,; var first_result; // Results are keyed by longUrl, so we need to grab the first ...
... SCOLR Pharma, Inc. (NYSE AMEX: DDD ... as the Chairman of its Board of Directors.  Johnson ... the Board.   Johnson previously served as ... Under Johnson,s leadership, Matrixx successfully developed and launched the ...
Cached Medicine Technology:Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 2Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 3Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 4Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 5Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 6Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 7Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 8Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 9SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director 2SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director 3
(Date:7/29/2015)... ... , ... According to the Miami Herald on July 18th acupuncture ... disorders. Acu-detox may begin taking off in the South Florida community as more detox ... acupuncture is not a new practice, it is not widely used, but has yielded ...
(Date:7/29/2015)... ... July 29, 2015 , ... San Fernando Valley skin doctor ... a limited time only, patients can get the complete treatment process with a 10 ... prefer a non-invasive treatment and have loose or sagging skin. , As the ...
(Date:7/29/2015)... ... 29, 2015 , ... Today marks a significant achievement in bringing new monies ... and is led by a group of experienced investors, has tapped into an investor ... dollars to be a part of the fund. The Sofia Fund II is ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... CanAm Enterprises, ... by USCIS over the past month! I-829 approvals have been granted to investors in ... Los Angeles, the Kimpton Lafayette Hotel project in Philadelphia, and the Valley Forge Convention ...
(Date:7/29/2015)... CA (PRWEB) , ... July 29, 2015 , ... ... Honduras with the Hackett Hemwall Foundation in March, Steven W. Meier M.D., a ... bono prolotherapy treatments to qualifying patients with demonstrated financial need. , “We are ...
Breaking Medicine News(10 mins):Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 2Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 3Health News:San Fernando Valley Dermatology Office, Castle Dermatology Institute, is Now Offering a Promotional Price on Ultherapy 2Health News:Sofia Fund Surpasses Investor Goals 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 3Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2
... horticultural production, growers often depend on systems that use ... are efficient, fluorescent lamps can produce plants with shorter ... indicated that this reduced shoot elongation is due to ... lamps, which emit little far red irradiation. ...
... bypass surgery is considered the gold standard for most patients ... serious types of heart disease and one that affects thousands. ... favorable long-term outcomes for lower-risk patients with this condition who ... A more minimally invasive procedure than surgery, angioplasty ...
... 2011)The New York Stem Cell Foundation (NYSCF) has received ... launch the NYCF-Golub Stem Cell Initiative for Parkinson,s Disease. ... to use a novel approach to understand Parkinson,s disease ... a genetically diverse population of Parkinson,s patients. ...
... Children born to mothers who smoked during pregnancy have lower ... of heart attack and stroke later in life, a new ... children and found that those whose mothers smoked during pregnancy ... compared to a normal level of 1.5 mmol/L in children ...
... plays a relatively small role in a nurse,s decision ... nursing home, according to new research from Rice University, ... In a comprehensive study of certified nursing assistants, researchers ... emotional well-being are better predictors of turnover in long-term ...
... of New Hampshire has launched a joint research laboratory ... promote international research in agricultural development and the environment, ... Sciences and Agriculture (COLSA) at UNH recently. The laboratory ... Institute for Agricultural Resources and Regional Planning (IARRP) in ...
Cached Medicine News:Health News:Artificial light quality affects herbivore preference for seedlings 2Health News:Angioplasty with stents may be safe in long-term for low-risk heart patients 2Health News:Angioplasty with stents may be safe in long-term for low-risk heart patients 3Health News:The New York Stem Cell Foundation announces new initiative for Parkinson's disease 2Health News:It's not about the money for long-term care nurses 2Health News:UNH launches joint Sustainable Agro-Ecosystems Lab with Chinese Academy 2
Measles IgM Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the in vitro determination of Measles IgM antibodies in human serum. For in vitro diagnostic use. High complexity test....
Measles IgM ELISA test is an enzyme linked immunosorbent assay (ELISA) for the detection of IgG class antibodies to Measles (Rubeola) in human serum or plasma....
... Digisonics has set the standard in ... review station, the only fully integrated ... multi-modality reporting., ,DigiView cardiology solutions bring ... professional reporting choices, an integrated clinical ...
... Model 4420 Colloid Osmometer. Rapid measurement ... the prediction of edema onset in ... dividing sample and reference chambers to ... vascular membrane in the establishment of ...
Medicine Products: